Skip to main content
Transforming Care and Inspiring Hope for all children...

Jaspers Research Reveals Fourth-generation Vaping Devices Increase Risk to Immune Cells

July 7, 2022
With the FDA ordering Juul to stop selling their e-cigarette devices, UNC School of Medicine researchers led by Ilona Jaspers, PhD, published the first study to compare the respiratory immune health effects of different types of devices.

Vogt Wins $3.1M NIAID Grant to Develop New Monoclonal Antibodies

March 24, 2022
Matthew Vogt, MD, PhD, assistant professor of Pediatrics in the Division of Infectious Diseases and of Microbiology & Immunology, has been granted an R01 from the National Institute of Allergy and Infectious Diseases (NIAID).

Vogt and Hernandez on Pandemic Preparedness in Lancet Microbe

February 8, 2022
The COVID-19 pandemic has demonstrated a critical need to establish a pre-emptive stockpile of tangible immunobiological countermeasures to accelerate the response to potential pandemic threats. To address this need we have established a pandemic response repository through microbial and immunological surveillance and epidemiology (PREMISE) initiative.

Mother-infant Hepatitis B Treatment, Prevention Feasible in Sub-Saharan Africa

August 25, 2021
A study in Lancet Global Health led by UNC School of Medicine’s Peyton Thompson, MD, MSCR and Jonathan Parr, MD, MPH showed the feasibility and acceptance of hepatitis B virus testing, treatment, and vaccination programs in the Democratic Republic of the Congo.

Ciccone receives Thrasher Research Foundation Early Career Award

June 21, 2019
Emily Ciccone, MD, MHS, will use the $25,000 award to differentiate viral and bacterial respiratory infections among malaria-negative children. The overall goal is to reduce unnecessary antibiotic use without compromising safety in an area where access to care is a real issue.